Adult

Aciclovir

Warning

General Information

Formulary antimicrobial: Use in accordance with Trust guidelines

For all information regarding contra-indications, interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).

Dosing in obesity

For intravenous administration: Use adjusted body weight. Take renal function into account when deciding dosing.

Renal and hepatic impairment

Renal impairment

Intravenous aciclovir

eGFR (mL/min/1.73m2)

IV Dose

More than 50

Dose as in normal renal function

25-50

5-10mg/kg BD

10-25

5-10mg/kg OD

Less than 10 

2.5-5mg/kg OD

HD/HDF

2.5-5mg/kg OD

Dialysed: give after dialysis

APD/CAPD

2.5-5mg/kg OD

Not dialysed

 

Oral aciclovir

eGFR (mL/min/1.73m2)

Herpes simplex virus (HSV)

Varicella zoster virus (VZV)

More than 25

No adjustment

10-25

200mg po TDS-QDS

800mg po BD-TDS

Less than 10 

200mg po BD

400mg-800mg po BD

HD/HDF

As for eGFR less than 10

Dialysed: give after dialysis

APD/CAPD

As for eGFR less than 10

Not dialysed

 

Hepatic impairment

No dose adjustment required

Additional information

  • Ensure patients on IV aciclovir and high dose oral aciclovir are adequately hydrated to minimise risk of renal impairment.

References

Editorial Information

Next review date: 01 Mar 2028